However, our previous study revealed that despite normal levels of BTLA expression, CD4+ T cells from lupus patients display an altered functionality of the BTLA signaling pathway (22), and may thus consequently be refractory to Treg-mediated suppression (Figure 7C). The gene discussed is BTLA; the disease is systemic lupus erythematosus.